Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Blueprint to Address Patent Thickets, Improve Competition, and Lower Prescription Drug Prices
How Egregious Orange Book Manipulation Extended an Insulin Monopoly
Our New Study: The Burden of Patent Thickets
Medicare Negotiation and the Momentum for Patent Reform
Drug Patents and the Innovation Myth
I-MAK’s Quest To Trim The Biopharmaceutical Patent Thicket
Defending the Inflation Reduction Act with Patent Data
Patent Reform is an Anti-Monopoly Issue
Bipartisan Calls for Patent Reform Keep Coming
Turning Pandemic Lessons Into Action